# Diversified Healthcare Trust Common Shares of Beneficial Interest (DHC) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Real Estate / Equity Real Estate Investment Trusts (REITs). Price $7.51, market value $1.8 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Diversified Healthcare Trust Common Shares of Beneficial Interest reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 1.2×**. Each dollar of revenue is priced at 1.2×.
- **Price / book: 1.1×**. The shares trade at 1.1× book value; book value is a meaningful part of the valuation.

## Profitability
- **Net margin: -18.6%**. The company reported a net loss over the last twelve months.
- **Return on equity: -17.2%**. Return on equity is negative because earnings are negative.
- **Return on assets: -6.1%**. Each dollar of assets produces -6.1% of profit.

## Growth
- **Revenue growth (1 yr): 2.8%** (3-yr 6.2%/yr, 5-yr -1.2%/yr). Revenue grew 2.8% over the last year, against -1.2% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 23.2%**. Earnings per share rose 23.2%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 1.47**. Debt is 1.47 times equity, a leveraged balance sheet, which is normal for real estate.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 0.53%** ($0.04 per share, trailing). Diversified Healthcare Trust Common Shares of Beneficial Interest yields 0.53%, a modest yield more typical of a growth-oriented payer.
- **Consecutive years of increases: 4**. 4 straight years of increases.
- **Dividend growth (5 yr): -26.0%/yr** (1-yr 0.0%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: buy** (4 analysts). 4 analysts cover Diversified Healthcare Trust Common Shares of Beneficial Interest; the consensus is buy, with an average price target of $10.15 (+35% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 94.3%** (YTD 55.5%, 3-mo -11.9%). The shares are up 94.3% over twelve months including dividends.
- **From 52-week high: -22.3%** (91.6% above the low). Trading 22% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 30**. An RSI of 30 is oversold; bounces are common, but oversold can stay oversold in a real decline.
- **Beta (1 yr): 0.68** (volatility 39%). Beta of 0.68 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=DHC · Page: https://foliofundamentals.com/stocks/dhc

Not investment advice.